Radiotherapy is a standard treatment method for the nasopharyngeal carcinoma due to the anatomy of these tumors and their easy locoregional spreading. Surgery is used only in case of recurrent or persistent lymph node involvement. Nasopharyngeal carcinomas are dose dependent. Results of conventional and fractionation radiotherapy has reached a stable level. Improvement of local control and overall survival depends on new technologies and research results. Concomitant chemoradiotherapy represents a standard method in the treatment of locally progressive disease. Hyperfractionated or accelerated radiotherapy combined with chemotherapy has been used in some clinical studies to shorten the treatment time.